Hyaluronic acid holds water — up to a thousand times its own weight — which is why it works so well applied to skin or injected into a joint.
Swallowing it raises a different question. The molecule is enormous, and the body has efficient machinery for taking large molecules apart. So what actually arrives?
An isotope-tracing study answered that with a number, and the number is smaller than I expected.
The size problem
Hyaluronic acid is a repeating chain of two sugars — glucuronic acid and N-acetylglucosamine — found throughout vertebrate tissue as a component of the extracellular matrix[3].
In the human body it’s synthesised at the cell surface, most commonly at a molecular weight of 1 to 8 million daltons[3]. That’s very large for something meant to cross an intestinal wall.
As one review puts it plainly: as a macromolecular nutrient, HA cannot be directly absorbed after oral intake owing to its high molecular weight and polyanionic nature[3].
So absorption, if it happens, requires the molecule to be taken apart first. Specific gut microbes have been proposed to degrade HA into oligosaccharides, making absorption of the fragments possible[3]. *Bacteroides* species are prominent among them[3].
This is the same shape of question we looked at with collagen peptides — a large molecule, a digestive system designed to dismantle it, and a claim that something useful survives.
What the tracing study found
A study using carbon-13 labelled sodium hyaluronate in mice, analysed by LC-MS, followed the molecule through[2].
High-molecular-weight material (1.6 MDa) was partially depolymerised in the stomach to fragments of roughly 150–600 kDa, through acid hydrolysis and microbial action[2].
Then the substantial part. Around 97% of the administered dose was degraded by gut microbiota into unsaturated oligosaccharides — mostly disaccharides[2].
Those small fragments did enter the circulation. But at approximately 0.2% of the dose, irrespective of the starting molecular weight[2].
And this is the finding that matters most:
Concentrations in peripheral tissues such as skin or joints remained below the detection limit[2].
The authors’ conclusion follows directly: a direct action of hyaluronate or its metabolites in peripheral tissues, including the skin, is rather improbable[2].
A separate review reached the same reading. The poor bioavailability of around 0.2% indicates that any mechanism must be a systemic regulatory function, rather than direct effects of hyaluronan at distant sites like skin and joints[3].
So the mechanism would have to be different
This is where I had to revise the picture.
I’d assumed oral HA worked the way oral collagen was proposed to — fragments arriving at the skin and doing something there. The tracing data closes that route. If skin concentrations are below detection, the fragments aren’t acting at the skin.
An alternative has been proposed. Hyaluronan or its fragments may interact with hyaluronan-binding receptors in the gut epithelium — CD44, toll-like receptor 4, and layilin — mediating intestinal barrier enhancement and anti-inflammatory effects[2].
Under that model the action is local, in the gut, with any skin effect being downstream and indirect. It’s a coherent hypothesis. It is also a considerably more modest claim than the marketing usually makes.
What the trials look like
Human trials do exist, and several report positive findings.
A 12-week placebo-controlled randomised double-blind trial gave 120 mg daily to 40 healthy Asian adults aged 35–64, assessing wrinkles, stratum corneum water content, transepidermal water loss and elasticity[4].
A larger randomised, double-blind, placebo-controlled trial enrolled 150 healthy adults to test oral sodium hyaluronate on skin hydration, barrier function and signs of ageing[2].
Others have used doses in the 120–240 mg/day range.
Two things are worth noting about this literature. The sample sizes are modest — 40 and 150 are small numbers for detecting subtle changes in skin measurements. And skin hydration endpoints are sensitive to season, ambient humidity and baseline status, which makes consistency across trials harder to achieve.
There’s also the funding question that recurs throughout this category. In vitro work in this area has been conducted with substances donated by the companies that make them[1], which is disclosed appropriately but is worth registering when reading conclusions.
It depends on your gut bacteria
Here’s a dependency that echoes something we’ve seen before.
Because absorption requires microbial degradation, your gut microbiota determines the bioavailability of what you swallow[3].
The enzymes involved are hyaluronidases, produced by particular bacteria. Enterobacteriaceae capable of producing them are described as widespread in the gut of both Asian and Caucasian populations[4] — which is reassuring as far as it goes, though “widespread” is not the same as “uniform.”
This is the same structural issue as equol production with isoflavones. When an ingredient requires a microbial conversion step, individual variation in the microbiome becomes a variable the trial can’t control for — and one that helps explain why results across studies don’t line up neatly.
If you’re in Korea
Two practical notes.
Check which category the product sits in. Hyaluronic acid appears in Korea as a health functional food ingredient, as a cosmetic ingredient, and as an injectable medical product. These are three separate regulatory categories with different evidence requirements and different permitted claims. Evidence from one doesn’t transfer to another — an injectable’s performance says nothing about a capsule.
Look up the approved wording. Whatever the packaging suggests, the recognised functional claim for an oral product is specific and checkable on the official food safety portal[5]. If the advertising promises considerably more than that wording, you’ve located the gap.
Closing
Oral hyaluronic acid is a clearer case than most, because the pharmacokinetic question has an actual number attached to it.
Roughly 97% degraded by gut bacteria. About 0.2% reaching the circulation. Skin and joint concentrations below the detection limit.
That doesn’t mean nothing happens — the gut-receptor hypothesis is plausible and being investigated. What it does mean is that the intuitive story, where you swallow hyaluronic acid and it goes to your skin, isn’t supported by the tracing data. If there’s an effect, it works by a different route than the one most people picture.
Which is a useful distinction to carry into any ingredient marketed on the strength of what it does when applied directly.
At a Glance
- Hyaluronic acid in the body is typically 1–8 million daltons — too large to be absorbed directly
- Absorption requires gut microbiota to degrade it into oligosaccharides first
- Isotope tracing: ~97% degraded by gut bacteria, mostly to disaccharides
- Only about 2% enters the circulation, regardless of starting molecular weight
- Skin and joint concentrations remained below the detection limit — direct action there is described as “rather improbable”
- The proposed alternative is local action in the gut via CD44, TLR4 and layilin receptors
- Human trials are modest in size (40 and 150 participants in two examples) at 120–240 mg/day
- Bioavailability depends on individual gut microbiota — the same structural issue as equol and isoflavones
※ This article is for general information and does not replace medical advice, diagnosis or treatment. It does not evaluate any specific product. Approved functional claims differ by country and by product category — confirm current wording on official sources. If you have a skin or joint condition, please consult a clinician rather than self-treating with supplements.
References
- “Non-Animal Hyaluronic Acid and Probiotics Enhance Skin Health via the Gut–Skin Axis: An In Vitro Study on Bioavailability and Cellular Impact”, PMC (including funding and material disclosure), https://pmc.ncbi.nlm.nih.gov/articles/PMC11817077/
- “Oral sodium hyaluronate improves skin hydration, barrier function and signs of aging: a randomized, double-blind, placebo-controlled trial in 150 healthy adults”, Scientific Reports (including ¹³C tracing data and receptor hypothesis), https://www.nature.com/articles/s41598-025-32758-5
- Šimek M, et al. “Molecular weight and gut microbiota determine the bioavailability of orally administered hyaluronic acid”, Carbohydrate Polymers, https://www.sciencedirect.com/science/article/abs/pii/S0144861723003454
- “Oral Hyaluronan Relieves Wrinkles and Improves Dry Skin: A 12-Week Double-Blinded, Placebo-Controlled Study”, Nutrients 2021;13(7):2220, https://www.mdpi.com/2072-6643/13/7/2220
- Food Safety Korea (MFDS), recognised functional ingredient and approved wording lookup, https://www.foodsafetykorea.go.kr/